Background Cytokines are key mediators of the inflammation in ulcerative colitis (UC); there
are inconsistent data on cytokines profile in patients with UC. C‐reactive protein/albumin …

Background A simple serum biomarker for clinical outcome in patients with ulcerative colitis
(UC) remains an unmet need. Some studies have shown an association between C-reactive …

Background Several cytokines are overexpressed in the colonic mucosa of patients with
ulcerative colitis (UC). The measurement of these parameters in plasma could be useful in …

Aims Ulcerative colitis (UC), characterized by chronic inflammation and its recurrence in the
large intestine, is well known as inflammatory bowel disease (IBD). Suitable biomarkers …

Crohn's disease (CD) and ulcerative colitis (UC) are characterized by overexpression of
proinflammatory cytokines. We determined the association of serum levels of interleukin (IL) …

OBJECTIVE: Serum biomarkers are commonly used for diagnosing and monitoring the
disease activity of ulcerative colitis (UC) patients. However, their role in predicting active …

Abstract Background and Aims Evaluating disease activity is important in ulcerative colitis.
Laboratory markers should be a non-invasive alternative to endoscopy for patients. The …

Background: In recent years, various biomarkers of ulcerative colitis (UC) have emerged;
however, few studies have simultaneously examined the utility of multiple biomarkers for …

Introduction This study aimed to compare the accuracy of selected laboratory markers in
assessing disease activity in patients with ulcerative colitis (UC). The analysis included …

Abstract Background/Aims Finding differences in systemic inflammatory response in
ulcerative colitis (UC), UC with Clostridium difficile infection (CDI), and CDI could lead to a …